China Resources Pharma Files for $1 Billion IPO in Hong Kong

China Resources Pharmaceutical Group, China's second largest pharma, filed for a Hong Kong IPO that will raise at least $1 billion. It is planned for Q3 of this year. Based in Beijing, CR Pharma has a broad range of offerings in China and is also a major distributor of pharmaceuticals and general healthcare products. According to media reports, there are five China pharmas that are planning Hong Kong IPOs this year with an expected transaction total of $5 billion. Only Simcere Pharma, which was privatized from its US listing three years ago, was mentioned as part of that group. More details.... Share this with colleagues: // //